Involvement of ERK1/2 pathway in neuroprotective effects of pyrroloquinoline quinine against rotenone-induced SH-SY5Y cell injury.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neuroscience

• Publication date

  2014-06-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuroscience.2014.04.022PMID 24755484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple pqqA genes respond differently to environment and one contributes dominantly to pyrroloquinoline quinone synthesis

  2015cited by this paper
• Differential Effects of Methyl-4-Phenylpyridinium Ion, Rotenone, and Paraquat on Differentiated SH-SY5Y Cells

  2013cited by this paper
• Pyrroloquinoline Quinine Protects Rat Brain Cortex Against Acute Glutamate-Induced Neurotoxicity

  2013cited by this paper
• Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

  2013cited by this paper
• Mitochondrial Enhancement for Neurodegenerative Movement Disorders: A Systematic Review of Trials Involving Creatine, Coenzyme Q10, Idebenone and Mitoquinone

  2013cited by this paper
• Therapies in Parkinson's disease.

  2012cited by this paper
• Distinct Effects of Rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on Cellular Bioenergetics and Cell Death

  2012cited by this paper
• Pyrroloquinoline quinone rescues hippocampal neurons from glutamate-induced cell death through activation of Nrf2 and up-regulation of antioxidant genes.

  2012cited by this paper
• Pyrroloquinoline-quinone and its versatile roles in biological processes

  2012cited by this paper
• The neuroprotective action of pyrroloquinoline quinone against glutamate-induced apoptosis in hippocampal neurons is mediated through the activation of PI3K/Akt pathway.

  2011cited by this paper
• The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors.

  2011cited by this paper
• Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model

  2011cited by this paper
• Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults

  2011cited by this paper
• The specificity of neuroprotection by antioxidants

  2009cited by this paper
• Protective effect of histamine H2 receptor antagonist ranitidine against rotenone-induced apoptosis.

  2009cited by this paper
• A highly reproducible rotenone model of Parkinson's disease.

  2009cited by this paper
• Pyrroloquinoline Quinone Stimulates Mitochondrial Biogenesis through cAMP Response Element-binding Protein Phosphorylation and Increased PGC-1α Expression*

  2009cited by this paper
• Potential physiological importance of pyrroloquinoline quinone.

  2009cited by this paper
• Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat

  2008cited by this paper
• Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1.

  2008cited by this paper
• Mitochondrial Approaches for Neuroprotection

  2008cited by this paper
• Activation of Ras signaling pathways by pyrroloquinoline quinone in NIH3T3 mouse fibroblasts.

  2007cited by this paper
• Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes.

  2007cited by this paper
• Pyrroloquinoline Quinone (PQQ) Prevents Cognitive Deficit Caused by Oxidative Stress in Rats

  2007cited by this paper
• MitoQ--a mitochondria-targeted antioxidant.

  2007cited by this paper
• Rotenone Model of Parkinson Disease

  2005cited by this paper
• Biochemistry: Role of PQQ as a mammalian enzyme cofactor?

  2005cited by this paper
• Biochemistry: Is pyrroloquinoline quinone a vitamin?

  2005cited by this paper
• Pyrroloquinoline Quinone (PQQ) Decreases Myocardial Infarct Size and Improves Cardiac Function in Rat Models of Ischemia and Ischemia/Reperfusion

  2004cited by this paper
• Pyrroloquinoline‐quinone: a reactive oxygen species scavenger in bacteria

  2004cited by this paper
• Mechanism of Toxicity in Rotenone Models of Parkinson's Disease

  2003cited by this paper
• Pathological Mutations of the Human NDUFS4 Gene of the 18-kDa (AQDQ) Subunit of Complex I Affect the Expression of the Protein and the Assembly and Function of the Complex*

  2003cited by this paper
• Nutritional biochemistry: A new redox-cofactor vitamin for mammals

  2003cited by this paper
• Physiological importance of quinoenzymes and the O-quinone family of cofactors.

  2000cited by this paper
• Glutamate-induced increases in intracellular Ca2+ in cultured frog tectal cells mediated by direct activation of NMDA receptor channels.

  1991cited by this paper
• Quinone derivatives lower blood and liver acetaldehyde but not ethanol concentrations following ethanol loading to rats.

  1988cited by this paper
• A novel coenzyme from bacterial primary alcohol dehydrogenases

  1979cited by this paper
• GLUCOSE DEHYDROGENASE OF BACTERIUM ANITRATUM: AN ENZYME WITH A NOVEL PROSTHETIC GROUP.

  1964cited by this paper

• VEGF and the VEGF73-101 Fragment Prevent MPP+ Induced Mitochondrial Dysfunction in a Cell Model of Parkinson’s Disease

  2025cites this paper
• Mitochonic acid 5 increases boar sperm quality by mitigating mitochondrial dysfunction

  2025cites this paper
• Regulating peroxisome proliferator activated receptor gamma coactivator-1alpha (PGC-1α): A potential role in neurological disorder and treatment.

  2025cites this paper
• Protective Effects of Pyrroloquinoline Quinone in CNS Disorders.

  2025cites this paper
• Proteomic Analysis Reveals Physiological Activities of Aβ Peptide for Alzheimer’s Disease

  2024cites this paper
• Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism

  2024cites this paper
• Pyrroloquinoline Quinone Improves Ram Sperm Quality through Its Antioxidative Ability during Storage at 4 °C

  2024cites this paper
• Natural antioxidants inhibit oxidative stress-induced changes in the morphology and motility of cells

  2023cites this paper
• Delivery of the reduced form of vitamin K2(20) to NIH/3T3 cells partially protects against rotenone induced cell death

  2022cites this paper
• Pyrroloquinoline Quinone Enhances Cognition of Neuroinflammatory Alzheimer’s Disease Mouse Model via Mitochondrial Biogenesis Regulation

  2021cites this paper
• Pyrroloquinoline Quinone Inhibits Rotenone-Induced Microglia Inflammation by Enhancing Autophagy

  2020cites this paper
• Neurotoxicity and apoptosis induced by pyrroloquinoline quinone and its ester derivative on primary cortical neurons.

  2020cites this paper
• Pyrroloquinoline quinone delays inflammaging induced by TNF‐α through the p16/p21 and Jagged1 signalling pathways

  2020cites this paper
• Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson’s disease model via AMPK activation

  2020cites this paper
• Pyrroloquinoline Quinone

  2019cites this paper
• The effect of Pyrroloquinoline quinone and Resveratrol on the Survival and Regeneration of Cerebellar Granular Neurons.

  2019cites this paper
• RETRACTED ARTICLE: The Neuroprotective Effect of Histamine H4 Receptor Antagonist on Dopaminergic Neurons in Parkinson’s Disease

  2019cites this paper
• Negative effects of ROS generated during linear sperm motility on gene expression and ATP generation in boar sperm mitochondria.

  2019cites this paper
• Integrated Analysis and Identification of Novel Biomarkers in Parkinson’s Disease

  2018cites this paper
• Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models.

  2018cites this paper
• Beneficial effects of a pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer’s disease

  2017cites this paper
• Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.

  2016cites this paper
• Neuroprotection Comparison of Different Nutraceutical Compounds Against Mechanistically Distinct Cell Death Inducing Agents

  2016cites this paper
• Inhibition of Endoplasmic Reticulum Stress is Involved in the Neuroprotective Effect of bFGF in the 6-OHDA-Induced Parkinson's Disease Model.

  2016cites this paper
• Pyrroloquinoline quinone enhances the resistance to oxidative stress and extends lifespan upon DAF-16 and SKN-1 activities in C. elegans.

  2016cites this paper
• Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson's disease.

  2016cites this paper
• The Life History of Pyrroloquinoline Quinone (PQQ): A Versatile Molecule with Novel Impacts on Living Systems

  2016cites this paper
• Orexin receptors exert a neuroprotective effect in Alzheimer’s disease (AD) via heterodimerization with GPR103

  2015cites this paper
• Pyrroloquinoline quinone (PQQ) producing Escherichia coli Nissle 1917 (EcN) alleviates age associated oxidative stress and hyperlipidemia, and improves mitochondrial function in ageing rats.

  2015cites this paper
• Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson's disease.

  2015cites this paper
• Fibroblast growth factor 1 attenuates 6-hydroxydopamine-induced neurotoxicity : an in vitro and in vivo investigation in experimental models of parkinson ’ s disease

  2014cites this paper
• Fibroblast growth factor 1attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of parkinson's disease.

  2014cites this paper